KNF Neuberger Launches Laboratory Metering Pump - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

KNF Neuberger Launches Laboratory Metering Pump


KNF Neuberger introduced the SIMDOS 02 fine dosing/metering pump for liquids that delivers 0.03–999 mL dosing volumes with a flow rate ranging from 0.03–20 mL/min. The pump’s splashproof housing protects the pump from water and dust intrusion, contributing to its long-term stability and reliability. Following calibration, repeatability is +/- 1% (full range). Several types of materials, including polymers and stainless steel, are available for the pump head for use with mild to aggressive or corrosive liquids. SIMDOS 02 is safe to run dry, is self-priming up to 6.6 ft. water, is effective against pressures of up to 85 psig, and transfers viscous media up to 500 centistokes. Integrated software permits the transfer parameters to be modified for a range of different viscosities.

Source: KNF Neuberger

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here